Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Hydrotherapy for treating unilateral lower limb lymphedema

Official title: Evaluation of the Effects of Hydrotherapy on Lower Extremity Volume, Quality of Life, and Functionality in Patients Diagnosed With Unilateral Lower Extremity Lymphedema

Run by Gaziosmanpasa Research and Education Hospital · NCT06839885 · Data updated 2026-11-12

This study tests whether adding hydrotherapy to a home exercise program can help people with swelling in one leg feel better and improve their daily activities.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment52 (estimated)
SponsorGaziosmanpasa Research and Education Hospital
Government
Locations1 site (Istanbul)
StatusRecruiting
StartedDecember 15, 2024
Main results expectedSeptember 15, 2025
Study endsDecember 15, 2025
Registry record updatedFebruary 21, 2025
Trial IDNCT06839885 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-75 with a diagnosis of primary or secondary unilateral lower extremity lymphedema who have previously undergone complex decongestive therapy.

Probably not a fit

Patients with serious systemic diseases, recent injuries or surgeries, or contraindications to hydrotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of hydrotherapy combined with a home exercise program on patients with unilateral lower extremity lymphedema. Participants will be divided into two groups: one receiving only a home exercise program and the other receiving hydrotherapy sessions alongside the exercise program. The study aims to assess changes in limb volume, quality of life, functionality, and exercise capacity before and after the intervention. The hydrotherapy sessions will be conducted in a controlled aquatic environment under the supervision of trained physiotherapists.

Why it matters

Potential benefit: If successful, this approach could significantly improve the quality of life and functionality for patients suffering from unilateral lower extremity lymphedema.

How similar studies have gone: While studies on upper extremity lymphedema have shown positive outcomes with exercise therapies, this specific approach for unilateral lower extremity lymphedema is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with primary or secondary unilateral lower extremity lymphedema diagnosis
* Patients who have received at least 2 weeks of complex decongestive therapy in the past
* Patients who are cooperative with hydrotherapy treatments
* Patients who are willing to participate in the treatment
* Patients aged 18-75

Exclusion Criteria:

* Patients who are unable to perform the evaluation parameters
* Patients with serious systemic diseases that may prevent exercise
* Patients who have had an injury and/or surgery in the last 6 months
* Conditions where hydrotherapy is contraindicated (severe fear of water, behavioral problems, shortness of breath at rest, incontinence, known chlorine allergy, open wound, acute systemic illness, epilepsy, tracheostomy, permanent drain, immunodeficiency)
* Patients with an active infection anywhere in the body
* Patients who have undergone sentinel lymph node biopsy
* Patients with active metastatic disease

Where it's running

  • GaziosmanpasaTREH
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.